Table 2.
VIS | Cell Line | ||||||||
---|---|---|---|---|---|---|---|---|---|
Cervix | Oropharynx | Liver | T-Cell | ||||||
SiHa | HeLa | CaSki | DoTc2 | 2A3 | SCC154 | 3B2 | SNU-182 | ACH-2 | |
1 | 13q22.1 1,2,3 LINC00393 4 KLF12 5 |
8q24.21 2,3 PCAT1 4 CASC19 4 MYC 5 |
2p11.2 LINC01830 PRR30 |
2p22.3 LINC00486 4 |
12q24.33 1 FBRSL1 | 6p12.2 7SK 4 |
4q13.3 6 | 1q25.1 1 TNR |
7p14.3 NT5C3A FKBP9 5 RP9 5 |
2 | 21p11.2 2 MIR3648-1 5 RNA5-8SNx |
21p11.2 2 MIR3648-1 5 RNA5-8SNx |
3q23 6 | 3p25.1 1 ANKRD28 4 RN7SL4P 4 |
16p13.3 METTL26 |
8q24.3 1,2 HGH1 4 |
13q31.3 5 | 2q34 UNC80 4 |
|
3 | 6p21.1 6 | 4p15.31 1 IGFBP7 5 |
20q11.23 1 RPN2 4 |
14q21.3 RN7SL2 4 |
16q11.2 6 | 4q31.3 5 | |||
4 | 10p14 6 | 6p21.32 ZBTB22 |
21p11.2 2 MIR3648-1 5 RNA5-8SNx |
21p11.2 2 MIR3648-1 5 RNA5-8SNx |
21p11.2 2 MIR3648-1 5 RNA5-8SNx |
8q24.13 1,2 HAS2-AS1 4 |
|||
5 | 11p15.4 6 | 7q21.3 GNGT1 4 |
22q11.22 PPIL2 4 |
21q21.1 7 | Yq12 6 | 17p11.1 6 | |||
6 | 14q21.3 MDGA2 4 |
8p11.21 PLAT 4 HGH1 4 |
21p11.2 2 MIR3648-1 5 RNA5-8SNx |
||||||
7 | 19q13.42 1 BRSK1 4 |
9p23 PTPRD 4 RN7SL5P RMRP 4 |
|||||||
8 | 20p11.1 6 | 10q26.11 1 TUBGCP2 4 RGS10 4 |
|||||||
9 | Xq27.3 1,6 | 14q21.3 RPPH1 4 RN7SL2 4 RPS29 4 RN7SL1 4 |
|||||||
10 | 16p13.3 METTL26 |
||||||||
11 | 21p11.2 2 MIR3648-1 5 RNA5-8SNx |
||||||||
12 | 22q11.22 PPIL2 4 |
||||||||
13 | Xq21.2 DACH2 4 |
VIS, viral integration site numbered in sequence; x, 1 to 3. 1 Chromosomal region and band recognized as a human common fragile site [41]. 2 Chromosomal region and band associated with carcinogenesis [44,45,46,47,48,49]. 3 Chromosomal region and band recognized as an HPV integration hotspot (i.e., 2q22.3, 3p14.2, 3q28, 8q24.21, 8q24.22, 13q22.1, 14q24.1, 17p11.1, 17q23.1, and 17q23.2) [42]. 4 Disrupted oncogenic, tumor suppressor, or cancer-associated gene(s) [44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78]. 5 Nearby oncogenic, tumor suppressor, or cancer-associated gene(s) [44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78]. 6 Viral integration site without disrupted gene(s). Nearby genes listed in Supplementary Table S4. 7 Disrupted uncharacterized long non-coding RNA gene listed in Supplementary Table S4.